JP2009543885A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009543885A5 JP2009543885A5 JP2009520962A JP2009520962A JP2009543885A5 JP 2009543885 A5 JP2009543885 A5 JP 2009543885A5 JP 2009520962 A JP2009520962 A JP 2009520962A JP 2009520962 A JP2009520962 A JP 2009520962A JP 2009543885 A5 JP2009543885 A5 JP 2009543885A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- ibuprofen
- famotidine
- unit dosage
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/489,269 US20080021078A1 (en) | 2006-07-18 | 2006-07-18 | Methods and medicaments for administration of ibuprofen |
| US11/489,272 US20080020040A1 (en) | 2006-07-18 | 2006-07-18 | Unit dose form for administration of ibuprofen |
| US89737107P | 2007-01-24 | 2007-01-24 | |
| PCT/US2007/073716 WO2008011426A2 (en) | 2006-07-18 | 2007-07-17 | Methods and medicaments for administration of ibuprofen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009543885A JP2009543885A (ja) | 2009-12-10 |
| JP2009543885A5 true JP2009543885A5 (enExample) | 2011-08-11 |
Family
ID=38957561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009520962A Pending JP2009543885A (ja) | 2006-07-18 | 2007-07-17 | イブプロフェンの投与のための方法および医薬 |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP2043637B8 (enExample) |
| JP (1) | JP2009543885A (enExample) |
| AT (1) | ATE539747T1 (enExample) |
| AU (1) | AU2007275360B2 (enExample) |
| BR (1) | BRPI0714937A2 (enExample) |
| CA (1) | CA2657928C (enExample) |
| DK (1) | DK2043637T3 (enExample) |
| ES (1) | ES2380747T3 (enExample) |
| IL (1) | IL196425A (enExample) |
| NZ (1) | NZ574200A (enExample) |
| PL (1) | PL2043637T3 (enExample) |
| PT (1) | PT2043637E (enExample) |
| WO (1) | WO2008011426A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8067451B2 (en) | 2006-07-18 | 2011-11-29 | Horizon Pharma Usa, Inc. | Methods and medicaments for administration of ibuprofen |
| US8067033B2 (en) | 2007-11-30 | 2011-11-29 | Horizon Pharma Usa, Inc. | Stable compositions of famotidine and ibuprofen |
| WO2008091957A2 (en) * | 2007-01-24 | 2008-07-31 | Horizon Therapeutics, Inc. | Pharmaceutical compositions containing famotidine and ibuprofen and having improved content uniformity |
| WO2013054352A1 (en) | 2011-08-17 | 2013-04-18 | Cadila Healthcare Limited | Pharmaceutical compositions of ibuprofen and famotidine |
| PL2912193T3 (pl) | 2012-10-29 | 2019-03-29 | Arizona Board Of Regents On Behalf Of University Of Arizona | Markery predykcyjne dla terapii przeciwnowotworowej z użyciem inhibitora poliaminy |
| WO2015163832A1 (en) | 2014-04-25 | 2015-10-29 | Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. | An ibuprofen and famotidine combined composition having improved stability |
| CA2952771A1 (en) | 2014-06-18 | 2015-12-23 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Carcinoma diagnosis and treatment based on odc1 genotype |
| WO2017075576A1 (en) * | 2015-10-30 | 2017-05-04 | Cancer Prevention Pharmaceuticals, Inc. | Eflornithine and sulindac, fixed dose combination formulation |
| KR20180069068A (ko) | 2015-10-30 | 2018-06-22 | 캔서 프리벤션 파마수티컬스, 인코포레이티드 | 에플로르니틴 및 설린닥, 고정된 용량 조합 제제 |
| US10945981B2 (en) | 2019-05-17 | 2021-03-16 | Cancer Prevention Pharmaceuticals, Inc. | Methods for treating familial adenomatous polyposis |
| CN116194102A (zh) * | 2020-07-15 | 2023-05-30 | 沙巴研究联合有限责任公司 | 用于治疗急性疼痛和降低胃灼热的严重程度和/或风险的包含布洛芬和法莫替丁的单位口服剂量组合物 |
| CA3124579A1 (en) | 2020-07-15 | 2022-01-15 | Schabar Research Associates Llc | Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn |
| EP4321156A4 (en) * | 2021-10-21 | 2025-05-07 | Han Wha Pharma Co., Ltd. | FILM-COATED TABLET WITH IMPROVED STABILITY CONTAINING MONTELUKAST OR ITS PHARMACEUTICALLY ACCEPTABLE SALT AND LEVOCETIRIZINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6056143B2 (ja) | 1979-08-02 | 1985-12-09 | 山之内製薬株式会社 | アミジン誘導体ならびにその製造法 |
| US4543370A (en) | 1979-11-29 | 1985-09-24 | Colorcon, Inc. | Dry edible film coating composition, method and coating form |
| US4802924A (en) | 1986-06-19 | 1989-02-07 | Colorcon, Inc. | Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products |
| HU196775B (en) | 1986-08-05 | 1989-01-30 | Richter Gedeon Vegyeszet | Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances |
| WO1994007541A1 (en) * | 1992-09-29 | 1994-04-14 | Merck & Co., Inc. | Ibuprofen-h2 antagonist combinations |
| US5976578A (en) * | 1996-10-10 | 1999-11-02 | Mcneil-Ppc, Inc. | Liquid antacid compositions |
| US6251945B1 (en) | 1999-01-14 | 2001-06-26 | Knoll Aktiengesellschaft | Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| DE10003757A1 (de) | 2000-01-28 | 2001-08-02 | Knoll Ag | Ibuprofen-Wirkstoffzubereitung |
| DE60237087D1 (de) * | 2001-06-01 | 2010-09-02 | Pozen Inc | Pharmazeutische zusammensetzungen für die koordinierte abgabe von nsaid |
| DE10153934A1 (de) | 2001-11-06 | 2003-05-22 | Basf Ag | Verfahren zur Kristallisation von Profenen |
| WO2004064815A1 (en) * | 2003-01-21 | 2004-08-05 | Smartrix Technologies Inc. | Oral dosage formulation |
| JP2006076956A (ja) * | 2004-09-10 | 2006-03-23 | Taiyo Yakuhin Kogyo Kk | 胃炎の治療・予防用配合剤 |
| EP1919288A4 (en) * | 2005-07-18 | 2009-12-16 | Horizon Therapeutics Inc | MEDICAMENTS CONTAINING FAMOTIDINE AND IBUPROFEN, AND ADMINISTRATION OF SAID DRUGS |
| DE102005049001A1 (de) | 2005-10-11 | 2007-04-12 | Basf Ag | Verfahren zur Herstellung von direkttablettierbaren Ibuprofen-Formulierungen |
-
2007
- 2007-07-17 PL PL07813027T patent/PL2043637T3/pl unknown
- 2007-07-17 JP JP2009520962A patent/JP2009543885A/ja active Pending
- 2007-07-17 WO PCT/US2007/073716 patent/WO2008011426A2/en not_active Ceased
- 2007-07-17 AU AU2007275360A patent/AU2007275360B2/en not_active Ceased
- 2007-07-17 AT AT07813027T patent/ATE539747T1/de active
- 2007-07-17 ES ES07813027T patent/ES2380747T3/es active Active
- 2007-07-17 NZ NZ574200A patent/NZ574200A/en not_active IP Right Cessation
- 2007-07-17 CA CA2657928A patent/CA2657928C/en not_active Expired - Fee Related
- 2007-07-17 DK DK07813027.5T patent/DK2043637T3/da active
- 2007-07-17 EP EP07813027A patent/EP2043637B8/en not_active Not-in-force
- 2007-07-17 EP EP12150096A patent/EP2438919A1/en not_active Withdrawn
- 2007-07-17 BR BRPI0714937-9A patent/BRPI0714937A2/pt not_active Application Discontinuation
- 2007-07-17 PT PT07813027T patent/PT2043637E/pt unknown
-
2009
- 2009-01-11 IL IL196425A patent/IL196425A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009543885A5 (enExample) | ||
| JP2006504795A5 (enExample) | ||
| JP2022180461A5 (enExample) | ||
| Eisen | Manifold beneficial effects of acetyl salicylic acid and nonsteroidal anti-inflammatory drugs on sepsis | |
| JP2021066744A5 (ja) | ブプロピオンおよびデキストロメトルファンを含む組成物 | |
| JP2009536147A5 (enExample) | ||
| JP2010525050A5 (enExample) | ||
| JP2013231087A5 (enExample) | ||
| JP2009525343A5 (enExample) | ||
| JP2012031131A5 (enExample) | ||
| MX2009000730A (es) | Liberacion controlada de formulaciones y metodos asociados. | |
| HRP20130057T1 (hr) | Lijeäśenje progresivne neurodegenerativne bolesti ibudilastom | |
| JP2012515184A5 (enExample) | ||
| JP2013505205A5 (enExample) | ||
| JP2009501801A5 (enExample) | ||
| JP2012500786A5 (enExample) | ||
| JP2011527301A5 (enExample) | ||
| JP2019517542A5 (enExample) | ||
| CA2570474A1 (en) | A combination composition comprising paracetamol and ibuprofen | |
| JP2013541583A5 (enExample) | ||
| Bhaskar et al. | Comparison of transdermal diclofenac patch with oral diclofenac as an analgesic modality following multiple premolar extractions in orthodontic patients: a cross over efficacy trial | |
| JP2013544290A5 (enExample) | ||
| JP2012533559A5 (enExample) | ||
| AR105184A1 (es) | Comprimidos de liberación inmediata que contienen un fármaco y procesos para formar los comprimidos | |
| JP2016530291A5 (enExample) |